[HTML][HTML] The gastric CB1 receptor modulates ghrelin production through the mTOR pathway to regulate food intake

LL Senin, O Al-Massadi, C Folgueira, C Castelao… - PloS one, 2013 - journals.plos.org
LL Senin, O Al-Massadi, C Folgueira, C Castelao, M Pardo, S Barja-Fernandez…
PloS one, 2013journals.plos.org
Over the years, the knowledge regarding the relevance of the cannabinoid system to the
regulation of metabolism has grown steadily. A central interaction between the cannabinoid
system and ghrelin has been suggested to regulate food intake. Although the stomach is the
main source of ghrelin and CB1 receptor expression in the stomach has been described,
little information is available regarding the possible interaction between the gastric
cannabinoid and ghrelin systems in the integrated control of energy homeostasis. The main …
Over the years, the knowledge regarding the relevance of the cannabinoid system to the regulation of metabolism has grown steadily. A central interaction between the cannabinoid system and ghrelin has been suggested to regulate food intake. Although the stomach is the main source of ghrelin and CB1 receptor expression in the stomach has been described, little information is available regarding the possible interaction between the gastric cannabinoid and ghrelin systems in the integrated control of energy homeostasis. The main objective of the present work was to assess the functional interaction between these two systems in terms of food intake using a combination of in vivo and in vitro approaches. The present work demonstrates that the peripheral blockade of the CB1 receptor by rimonabant treatment decreased food intake but only in food-deprived animals. This anorexigenic effect is likely a consequence of decreases in gastric ghrelin secretion induced by the activation of the mTOR/S6K1 intracellular pathway in the stomach following treatment with rimonabant. In support of this supposition, animals in which the mTOR/S6K1 intracellular pathway was blocked by chronic rapamycin treatment, rimonabant had no effect on ghrelin secretion. Vagal communication may also be involved because rimonabant treatment was no longer effective when administered to animals that had undergone surgical vagotomy. In conclusion, to the best of our knowledge, the present work is the first to describe a CB1 receptor-mediated mechanism that influences gastric ghrelin secretion and food intake through the mTOR pathway.
PLOS